Lingdi Zhao

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

Wenqun Xing, Lingdi Zhao, Baoxing Liu et al. · Frontiers in Immunology · 2021 · 72 citations · Full text

Medicine, Oncology, Surgery +16

Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients

Shuai Wang, Xiaohong Han, Xingsheng Hu et al. · Clinica Chimica Acta · 2014 · 49 citations

Medicine, Oncology, Metastasis +12

Association of Myeloid-derived Suppressor Cells and Efficacy of Cytokine-induced Killer Cell Immunotherapy in Metastatic Renal Cell Carcinoma Patients

Zibing Wang, Yong Zhang, Yuqing Liu et al. · Journal of Immunotherapy · 2013 · 47 citations

Medicine, Immunology, Oncology +17

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus

Lu Han, Jian Zhou, Keshu Zhou et al. · Journal for ImmunoTherapy of Cancer · 2020 · 46 citations · Full text

Medicine, Hematology, Oncology +17

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Wenqun Xing, Lingdi Zhao, Xiaomin Fu et al. · Journal of Thoracic Disease · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17